MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

Search

Pliant Therapeutics Inc

Închisă

1.45 3.57

Rezumat

Modificarea prețului

24h

Curent

Minim

1.4

Maxim

1.49

Indicatori cheie

By Trading Economics

Venit

-6.4M

-56M

Angajați

171

EBITDA

-10M

-59M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+467.38% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-20M

77M

Deschiderea anterioară

-2.12

Închiderea anterioară

1.45

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Pliant Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 22:07 UTC

Principalele dinamici ale pieței

Trade Desk Rises on S&P 500 Inclusion

14 iul. 2025, 17:06 UTC

Principalele dinamici ale pieței

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 iul. 2025, 16:47 UTC

Achiziții, Fuziuni, Preluări

NatWest to Sell Stake in Permanent TSB

14 iul. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14 iul. 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 iul. 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 iul. 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 iul. 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 iul. 2025, 23:01 UTC

Câștiguri

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 iul. 2025, 23:01 UTC

Câștiguri

China Vanke Expects 1H Loss to Widen >000002.SZ

14 iul. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 iul. 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 iul. 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 iul. 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 iul. 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14 iul. 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 iul. 2025, 18:30 UTC

Achiziții, Fuziuni, Preluări

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 iul. 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 iul. 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 iul. 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 iul. 2025, 16:53 UTC

Acțiuni populare

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 iul. 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 iul. 2025, 16:20 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

14 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 iul. 2025, 16:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparație

Modificare preț

Pliant Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

467.38% sus

Prognoză pe 12 luni

Medie 8 USD  467.38%

Maxim 17 USD

Minim 3 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPliant Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

6 ratings

1

Cumpărare

5

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

1.43 / 1.6Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.